Taysha Gene Therapies, Inc. (TSHA) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $738.0K | +97.3% |
| 2024 | $374.0K | -90.3% |
| 2023 | $3.87M | -81.2% |
| 2022 | $20.62M | +34.7% |
| 2021 | $15.30M | +18563.4% |
| 2020 | $82.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $738.0K | +97.3% |
| 2024 | $374.0K | -90.3% |
| 2023 | $3.87M | -81.2% |
| 2022 | $20.62M | +34.7% |
| 2021 | $15.30M | +18563.4% |
| 2020 | $82.0K | — |